Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SPRO
#3193
Spero Therapeutics, Inc. Common Stock
2.1
7
-0.46%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.46%
Monthly Change
-8.05%
6 month change
+10.15%
Cambio anual
+178.21%
Cierres anteriores
2.1
8
Open
2.1
7
Bid
Ask
Low
2.1
7
High
2.1
7
Volumen
8
Markets
Acciones
Atención Sanitaria
SPRO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.52 M
55.9 M
55.91 M
56.28 M
56.34 M
—
Valuation ratios
Enterprise value
-3.24 M
4.69 M
-8.63 M
132 M
57.3 M
185.36 M
Price to earnings ratio
16.75
-0.81
-0.56
-2.96
-2.38
-6.71
Price to sales ratio
0.67
1.16
0.87
3.26
2.55
7.85
Price to cash flow ratio
4.04
-2.37
1.82
4.95
1.66
6.05
Price to book ratio
0.21
1.21
0.17
0.89
0.74
3.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.13
0.19
0.18
0.03
0.14
0.53
Return on equity %
0.26
0.45
0.41
0.05
0.28
1.19
Return on invested capital %
113.69
—
—
—
195.47
—
Gross margin %
100
100
100
100
100
400
Operating margin %
138.04
144.41
250.78
17.22
145.46
557.88
EBITDA margin %
—
—
—
—
—
—
Net margin %
126.96
138.85
236.06
11.98
135.65
522.53
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.68
2.19
2.56
3.97
3.83
12.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.09
0.12
0.06
0.2
0.09
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
0.24
-0.43
-0.07
-0.32
-0.31
-1.13
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.41
0.98
0.88
0.56
0.86
3.28
Net current asset value per share
2.43
1.99
1.35
1.06
0.93
5.32
Tangible book value per share
1.21
0.85
0.61
0.59
0.47
2.52
Working capital per share
1.52
1.08
0.82
0.79
0.69
3.38
Book value per share
1.21
0.85
0.61
0.59
0.47
2.52
Noticias
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
Keutzer, COO de Spero Therapeutics, vende acciones por 44.000 dólares
Keutzer, COO de Spero Therapeutics, vende acciones por $44,000
Keutzer, Spero Therapeutics COO, sells $44k in shares
CEO de Spero Therapeutics vende acciones por $207k
Director ejecutiva de Spero Therapeutics vende acciones por 207.000 dólares
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK presenta solicitud de nuevo fármaco para antibiótico tebipenem HBr de Spero
GSK presenta la nueva solicitud de NDA para el antibiótico tebipenem HBr de Spero
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic